{"entity":{"type":"insider","cik":"0001614936","url":"/insider/0001614936","json_url":"/insider/0001614936.json","name":"Pomerantz Roger","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":51,"n_filings":21,"first":"2016-04-05","last":"2018-09-11","span_basis":"filed_date"},"name_variants":[{"name":"Pomerantz Roger","source":"filing","n_filings":21,"first_seen":"2016-04-05","last_seen":"2018-09-11"}],"transactions":[{"id":6283160,"accession":"0000899243-18-024194","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-18-024194","line_url":"/filing/0000899243-18-024194#line-1","is_derivative":false,"issuer_cik":"0001609809","issuer_name":"Seres Therapeutics, Inc.","issuer_ticker":"MCRB","issuer_name_source":null,"issuer_url":"/issuer/0001609809","owner_cik":"0001614936","owner_name":"Pomerantz Roger","owner_display_name":"Pomerantz Roger","owner_url":"/insider/0001614936","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1810.0,"shares_display":"1,810","price_per_share":9.0007,"price_display":"9.00","price_state":"stated","total_value":16291.267,"total_display":"16,291.27","total_whole":"16,291","shares_owned_after":213976.0,"shares_owned_after_display":"213,976","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-09-07","filed_date":"2018-09-11","scope":"insider"},{"id":6511100,"accession":"0000899243-18-023938","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-18-023938","line_url":"/filing/0000899243-18-023938#line-2","is_derivative":false,"issuer_cik":"0001609809","issuer_name":"Seres Therapeutics, Inc.","issuer_ticker":"MCRB","issuer_name_source":null,"issuer_url":"/issuer/0001609809","owner_cik":"0001614936","owner_name":"Pomerantz Roger","owner_display_name":"Pomerantz Roger","owner_url":"/insider/0001614936","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3013.0,"shares_display":"3,013","price_per_share":9.0393,"price_display":"9.04","price_state":"stated","total_value":27235.4109,"total_display":"27,235.41","total_whole":"27,235","shares_owned_after":215786.0,"shares_owned_after_display":"215,786","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-09-06","filed_date":"2018-09-06","scope":"insider"},{"id":6511096,"accession":"0000899243-18-023938","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-18-023938","line_url":"/filing/0000899243-18-023938#line-1","is_derivative":false,"issuer_cik":"0001609809","issuer_name":"Seres Therapeutics, Inc.","issuer_ticker":"MCRB","issuer_name_source":null,"issuer_url":"/issuer/0001609809","owner_cik":"0001614936","owner_name":"Pomerantz Roger","owner_display_name":"Pomerantz Roger","owner_url":"/insider/0001614936","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9505.0,"shares_display":"9,505","price_per_share":9.123,"price_display":"9.12","price_state":"stated","total_value":86714.115,"total_display":"86,714.12","total_whole":"86,714","shares_owned_after":218799.0,"shares_owned_after_display":"218,799","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-09-05","filed_date":"2018-09-06","scope":"insider"},{"id":6384572,"accession":"0001104659-18-046530","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-18-046530","line_url":"/filing/0001104659-18-046530#line-1","is_derivative":false,"issuer_cik":"0001614936","issuer_name":"Rubius Therapeutics, Inc.","issuer_ticker":"RUBY","issuer_name_source":null,"issuer_url":"/issuer/0001614936","owner_cik":"0001614936","owner_name":"Pomerantz Roger","owner_display_name":"Pomerantz Roger","owner_url":"/insider/0001614936","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100.0,"shares_display":"100","price_per_share":23.0,"price_display":"23.00","price_state":"stated","total_value":2300.0,"total_display":"2,300.00","total_whole":"2,300","shares_owned_after":100.0,"shares_owned_after_display":"100","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-07-20","filed_date":"2018-07-23","scope":"insider"},{"id":6089927,"accession":"0000899243-18-019814","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-18-019814","line_url":"/filing/0000899243-18-019814#line-2","is_derivative":false,"issuer_cik":"0001609809","issuer_name":"Seres Therapeutics, Inc.","issuer_ticker":"MCRB","issuer_name_source":null,"issuer_url":"/issuer/0001609809","owner_cik":"0001614936","owner_name":"Pomerantz Roger","owner_display_name":"Pomerantz Roger","owner_url":"/insider/0001614936","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1010.0,"shares_display":"1,010","price_per_share":9.0089,"price_display":"9.01","price_state":"stated","total_value":9098.989,"total_display":"9,098.99","total_whole":"9,099","shares_owned_after":228304.0,"shares_owned_after_display":"228,304","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-07-11","filed_date":"2018-07-12","scope":"insider"},{"id":6537854,"accession":"0000899243-18-019711","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000899243-18-019711","line_url":"/filing/0000899243-18-019711#line-6","is_derivative":false,"issuer_cik":"0001609809","issuer_name":"Seres Therapeutics, Inc.","issuer_ticker":"MCRB","issuer_name_source":null,"issuer_url":"/issuer/0001609809","owner_cik":"0001614936","owner_name":"Pomerantz Roger","owner_display_name":"Pomerantz Roger","owner_url":"/insider/0001614936","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5989.0,"shares_display":"5,989","price_per_share":9.0512,"price_display":"9.05","price_state":"stated","total_value":54207.6368,"total_display":"54,207.64","total_whole":"54,208","shares_owned_after":228304.0,"shares_owned_after_display":"228,304","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-07-10","filed_date":"2018-07-10","scope":"insider"},{"id":6537848,"accession":"0000899243-18-019711","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-18-019711","line_url":"/filing/0000899243-18-019711#line-4","is_derivative":false,"issuer_cik":"0001609809","issuer_name":"Seres Therapeutics, Inc.","issuer_ticker":"MCRB","issuer_name_source":null,"issuer_url":"/issuer/0001609809","owner_cik":"0001614936","owner_name":"Pomerantz Roger","owner_display_name":"Pomerantz Roger","owner_url":"/insider/0001614936","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10981.0,"shares_display":"10,981","price_per_share":9.1386,"price_display":"9.14","price_state":"stated","total_value":100350.9666,"total_display":"100,350.97","total_whole":"100,351","shares_owned_after":228304.0,"shares_owned_after_display":"228,304","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-07-09","filed_date":"2018-07-10","scope":"insider"},{"id":6537842,"accession":"0000899243-18-019711","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-18-019711","line_url":"/filing/0000899243-18-019711#line-2","is_derivative":false,"issuer_cik":"0001609809","issuer_name":"Seres Therapeutics, Inc.","issuer_ticker":"MCRB","issuer_name_source":null,"issuer_url":"/issuer/0001609809","owner_cik":"0001614936","owner_name":"Pomerantz Roger","owner_display_name":"Pomerantz Roger","owner_url":"/insider/0001614936","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15366.0,"shares_display":"15,366","price_per_share":9.144,"price_display":"9.14","price_state":"stated","total_value":140506.704,"total_display":"140,506.70","total_whole":"140,507","shares_owned_after":228304.0,"shares_owned_after_display":"228,304","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-07-06","filed_date":"2018-07-10","scope":"insider"},{"id":6250848,"accession":"0000899243-18-018742","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-18-018742","line_url":"/filing/0000899243-18-018742#line-4","is_derivative":false,"issuer_cik":"0001609809","issuer_name":"Seres Therapeutics, Inc.","issuer_ticker":"MCRB","issuer_name_source":null,"issuer_url":"/issuer/0001609809","owner_cik":"0001614936","owner_name":"Pomerantz Roger","owner_display_name":"Pomerantz Roger","owner_url":"/insider/0001614936","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4496.0,"shares_display":"4,496","price_per_share":9.1004,"price_display":"9.10","price_state":"stated","total_value":40915.3984,"total_display":"40,915.40","total_whole":"40,915","shares_owned_after":228304.0,"shares_owned_after_display":"228,304","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-06-29","filed_date":"2018-06-29","scope":"insider"},{"id":6250841,"accession":"0000899243-18-018742","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-18-018742","line_url":"/filing/0000899243-18-018742#line-2","is_derivative":false,"issuer_cik":"0001609809","issuer_name":"Seres Therapeutics, Inc.","issuer_ticker":"MCRB","issuer_name_source":null,"issuer_url":"/issuer/0001609809","owner_cik":"0001614936","owner_name":"Pomerantz Roger","owner_display_name":"Pomerantz Roger","owner_url":"/insider/0001614936","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":21560.0,"shares_display":"21,560","price_per_share":9.1547,"price_display":"9.15","price_state":"stated","total_value":197375.332,"total_display":"197,375.33","total_whole":"197,375","shares_owned_after":228304.0,"shares_owned_after_display":"228,304","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-06-28","filed_date":"2018-06-29","scope":"insider"},{"id":6678184,"accession":"0000899243-18-018520","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000899243-18-018520","line_url":"/filing/0000899243-18-018520#line-6","is_derivative":false,"issuer_cik":"0001609809","issuer_name":"Seres Therapeutics, Inc.","issuer_ticker":"MCRB","issuer_name_source":null,"issuer_url":"/issuer/0001609809","owner_cik":"0001614936","owner_name":"Pomerantz Roger","owner_display_name":"Pomerantz Roger","owner_url":"/insider/0001614936","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16991.0,"shares_display":"16,991","price_per_share":9.0288,"price_display":"9.03","price_state":"stated","total_value":153408.3408,"total_display":"153,408.34","total_whole":"153,408","shares_owned_after":228304.0,"shares_owned_after_display":"228,304","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-06-27","filed_date":"2018-06-27","scope":"insider"},{"id":6678178,"accession":"0000899243-18-018520","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-18-018520","line_url":"/filing/0000899243-18-018520#line-4","is_derivative":false,"issuer_cik":"0001609809","issuer_name":"Seres Therapeutics, Inc.","issuer_ticker":"MCRB","issuer_name_source":null,"issuer_url":"/issuer/0001609809","owner_cik":"0001614936","owner_name":"Pomerantz Roger","owner_display_name":"Pomerantz Roger","owner_url":"/insider/0001614936","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":21224.0,"shares_display":"21,224","price_per_share":9.194,"price_display":"9.19","price_state":"stated","total_value":195133.456,"total_display":"195,133.46","total_whole":"195,133","shares_owned_after":228304.0,"shares_owned_after_display":"228,304","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-06-26","filed_date":"2018-06-27","scope":"insider"},{"id":6678170,"accession":"0000899243-18-018520","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-18-018520","line_url":"/filing/0000899243-18-018520#line-2","is_derivative":false,"issuer_cik":"0001609809","issuer_name":"Seres Therapeutics, Inc.","issuer_ticker":"MCRB","issuer_name_source":null,"issuer_url":"/issuer/0001609809","owner_cik":"0001614936","owner_name":"Pomerantz Roger","owner_display_name":"Pomerantz Roger","owner_url":"/insider/0001614936","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":26752.0,"shares_display":"26,752","price_per_share":9.2144,"price_display":"9.21","price_state":"stated","total_value":246503.6288,"total_display":"246,503.63","total_whole":"246,504","shares_owned_after":228304.0,"shares_owned_after_display":"228,304","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-06-25","filed_date":"2018-06-27","scope":"insider"},{"id":6062656,"accession":"0000899243-18-017794","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-18-017794","line_url":"/filing/0000899243-18-017794#line-3","is_derivative":false,"issuer_cik":"0001609809","issuer_name":"Seres Therapeutics, Inc.","issuer_ticker":"MCRB","issuer_name_source":null,"issuer_url":"/issuer/0001609809","owner_cik":"0001614936","owner_name":"Pomerantz Roger","owner_display_name":"Pomerantz Roger","owner_url":"/insider/0001614936","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":40057.0,"shares_display":"40,057","price_per_share":9.3557,"price_display":"9.36","price_state":"stated","total_value":374761.2749,"total_display":"374,761.27","total_whole":"374,761","shares_owned_after":238768.0,"shares_owned_after_display":"238,768","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-06-22","filed_date":"2018-06-22","scope":"insider"},{"id":6062652,"accession":"0000899243-18-017794","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-18-017794","line_url":"/filing/0000899243-18-017794#line-2","is_derivative":false,"issuer_cik":"0001609809","issuer_name":"Seres Therapeutics, Inc.","issuer_ticker":"MCRB","issuer_name_source":null,"issuer_url":"/issuer/0001609809","owner_cik":"0001614936","owner_name":"Pomerantz Roger","owner_display_name":"Pomerantz Roger","owner_url":"/insider/0001614936","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18987.0,"shares_display":"18,987","price_per_share":9.0638,"price_display":"9.06","price_state":"stated","total_value":172094.3706,"total_display":"172,094.37","total_whole":"172,094","shares_owned_after":278825.0,"shares_owned_after_display":"278,825","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-06-21","filed_date":"2018-06-22","scope":"insider"},{"id":6062648,"accession":"0000899243-18-017794","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-18-017794","line_url":"/filing/0000899243-18-017794#line-1","is_derivative":false,"issuer_cik":"0001609809","issuer_name":"Seres Therapeutics, Inc.","issuer_ticker":"MCRB","issuer_name_source":null,"issuer_url":"/issuer/0001609809","owner_cik":"0001614936","owner_name":"Pomerantz Roger","owner_display_name":"Pomerantz Roger","owner_url":"/insider/0001614936","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":26492.0,"shares_display":"26,492","price_per_share":9.3255,"price_display":"9.33","price_state":"stated","total_value":247051.146,"total_display":"247,051.15","total_whole":"247,051","shares_owned_after":297812.0,"shares_owned_after_display":"297,812","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-06-20","filed_date":"2018-06-22","scope":"insider"},{"id":6677960,"accession":"0000899243-18-012352","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-18-012352","line_url":"/filing/0000899243-18-012352#line-1","is_derivative":false,"issuer_cik":"0001609809","issuer_name":"Seres Therapeutics, Inc.","issuer_ticker":"MCRB","issuer_name_source":null,"issuer_url":"/issuer/0001609809","owner_cik":"0001614936","owner_name":"Pomerantz Roger","owner_display_name":"Pomerantz Roger","owner_url":"/insider/0001614936","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":233.0,"shares_display":"233","price_per_share":9.0,"price_display":"9.00","price_state":"stated","total_value":2097.0,"total_display":"2,097.00","total_whole":"2,097","shares_owned_after":324304.0,"shares_owned_after_display":"324,304","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-05-09","filed_date":"2018-05-10","scope":"insider"},{"id":4944257,"accession":"0001209191-17-046319","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-046319","line_url":"/filing/0001209191-17-046319#line-1","is_derivative":false,"issuer_cik":"0001478069","issuer_name":"CONTRAFECT Corp","issuer_ticker":"CFRX","issuer_name_source":null,"issuer_url":"/issuer/0001478069","owner_cik":"0001614936","owner_name":"Pomerantz Roger","owner_display_name":"Pomerantz Roger","owner_url":"/insider/0001614936","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.0001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":800.0,"shares_display":"800","price_per_share":1.24,"price_display":"1.24","price_state":"stated","total_value":992.0,"total_display":"992.00","total_whole":"992","shares_owned_after":800.0,"shares_owned_after_display":"800","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-07-25","filed_date":"2017-07-26","scope":"insider"},{"id":2131970,"accession":"0000899243-16-025823","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-16-025823","line_url":"/filing/0000899243-16-025823#line-2","is_derivative":false,"issuer_cik":"0001609809","issuer_name":"Seres Therapeutics, Inc.","issuer_ticker":"MCRB","issuer_name_source":null,"issuer_url":"/issuer/0001609809","owner_cik":"0001614936","owner_name":"Pomerantz Roger","owner_display_name":"Pomerantz Roger","owner_url":"/insider/0001614936","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":35.0,"price_display":"35.00","price_state":"stated","total_value":700000.0,"total_display":"700,000.00","total_whole":"700,000","shares_owned_after":183692.0,"shares_owned_after_display":"183,692","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-07-27","filed_date":"2016-07-28","scope":"insider"},{"id":3351408,"accession":"0000899243-16-024755","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000899243-16-024755","line_url":"/filing/0000899243-16-024755","is_derivative":false,"issuer_cik":"0001609809","issuer_name":"Seres Therapeutics, Inc.","issuer_ticker":"MCRB","issuer_name_source":null,"issuer_url":"/issuer/0001609809","owner_cik":"0001614936","owner_name":"Pomerantz Roger","owner_display_name":"Pomerantz Roger","owner_url":"/insider/0001614936","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":35435.0,"shares_display":"35,435","price_per_share":29.6519260618033,"price_display":"29.65","price_state":"stated","total_value":1050716.0,"total_display":"1,050,716.00","total_whole":"1,050,716","shares_owned_after":183692.0,"shares_owned_after_display":"183,692","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-07-06","filed_date":"2016-07-07","scope":"insider","n_lines":2},{"id":3351399,"accession":"0000899243-16-024755","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-16-024755","line_url":"/filing/0000899243-16-024755","is_derivative":false,"issuer_cik":"0001609809","issuer_name":"Seres Therapeutics, Inc.","issuer_ticker":"MCRB","issuer_name_source":null,"issuer_url":"/issuer/0001609809","owner_cik":"0001614936","owner_name":"Pomerantz Roger","owner_display_name":"Pomerantz Roger","owner_url":"/insider/0001614936","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":52776.0,"shares_display":"52,776","price_per_share":29.307980331969077,"price_display":"29.31","price_state":"stated","total_value":1546757.97,"total_display":"1,546,757.97","total_whole":"1,546,758","shares_owned_after":186597.0,"shares_owned_after_display":"186,597","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-07-05","filed_date":"2016-07-07","scope":"insider","n_lines":2},{"id":2305714,"accession":"0000899243-16-024380","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-16-024380","line_url":"/filing/0000899243-16-024380","is_derivative":false,"issuer_cik":"0001609809","issuer_name":"Seres Therapeutics, Inc.","issuer_ticker":"MCRB","issuer_name_source":null,"issuer_url":"/issuer/0001609809","owner_cik":"0001614936","owner_name":"Pomerantz Roger","owner_display_name":"Pomerantz Roger","owner_url":"/insider/0001614936","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":56789.0,"shares_display":"56,789","price_per_share":29.806911901952844,"price_display":"29.81","price_state":"stated","total_value":1692704.72,"total_display":"1,692,704.72","total_whole":"1,692,705","shares_owned_after":193692.0,"shares_owned_after_display":"193,692","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-07-01","filed_date":"2016-07-05","scope":"insider","n_lines":3},{"id":3069444,"accession":"0000899243-16-021796","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-16-021796","line_url":"/filing/0000899243-16-021796","is_derivative":false,"issuer_cik":"0001609809","issuer_name":"Seres Therapeutics, Inc.","issuer_ticker":"MCRB","issuer_name_source":null,"issuer_url":"/issuer/0001609809","owner_cik":"0001614936","owner_name":"Pomerantz Roger","owner_display_name":"Pomerantz Roger","owner_url":"/insider/0001614936","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":74049.0,"shares_display":"74,049","price_per_share":32.517868897621845,"price_display":"32.52","price_state":"stated","total_value":2407915.674,"total_display":"2,407,915.67","total_whole":"2,407,916","shares_owned_after":203999.0,"shares_owned_after_display":"203,999","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-06-02","filed_date":"2016-06-06","scope":"insider","n_lines":3},{"id":2625769,"accession":"0000899243-16-021563","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-16-021563","line_url":"/filing/0000899243-16-021563","is_derivative":false,"issuer_cik":"0001609809","issuer_name":"Seres Therapeutics, Inc.","issuer_ticker":"MCRB","issuer_name_source":null,"issuer_url":"/issuer/0001609809","owner_cik":"0001614936","owner_name":"Pomerantz Roger","owner_display_name":"Pomerantz Roger","owner_url":"/insider/0001614936","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":70951.0,"shares_display":"70,951","price_per_share":30.51173133571056,"price_display":"30.51","price_state":"stated","total_value":2164837.85,"total_display":"2,164,837.85","total_whole":"2,164,838","shares_owned_after":183692.0,"shares_owned_after_display":"183,692","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-06-01","filed_date":"2016-06-02","scope":"insider","n_lines":2},{"id":2305460,"accession":"0000899243-16-020965","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-16-020965","line_url":"/filing/0000899243-16-020965#line-2","is_derivative":false,"issuer_cik":"0001609809","issuer_name":"Seres Therapeutics, Inc.","issuer_ticker":"MCRB","issuer_name_source":null,"issuer_url":"/issuer/0001609809","owner_cik":"0001614936","owner_name":"Pomerantz Roger","owner_display_name":"Pomerantz Roger","owner_url":"/insider/0001614936","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9801.0,"shares_display":"9,801","price_per_share":30.0,"price_display":"30.00","price_state":"stated","total_value":294030.0,"total_display":"294,030.00","total_whole":"294,030","shares_owned_after":183692.0,"shares_owned_after_display":"183,692","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-05-24","filed_date":"2016-05-25","scope":"insider"},{"id":3069385,"accession":"0000899243-16-019547","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-16-019547","line_url":"/filing/0000899243-16-019547","is_derivative":false,"issuer_cik":"0001609809","issuer_name":"Seres Therapeutics, Inc.","issuer_ticker":"MCRB","issuer_name_source":null,"issuer_url":"/issuer/0001609809","owner_cik":"0001614936","owner_name":"Pomerantz Roger","owner_display_name":"Pomerantz Roger","owner_url":"/insider/0001614936","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8507.0,"shares_display":"8,507","price_per_share":24.309688491830258,"price_display":"24.31","price_state":"stated","total_value":206802.52,"total_display":"206,802.52","total_whole":"206,803","shares_owned_after":23035.0,"shares_owned_after_display":"23,035","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-05-06","filed_date":"2016-05-09","scope":"insider","n_lines":2},{"id":2495210,"accession":"0000899243-16-019420","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0000899243-16-019420","line_url":"/filing/0000899243-16-019420","is_derivative":false,"issuer_cik":"0001609809","issuer_name":"Seres Therapeutics, Inc.","issuer_ticker":"MCRB","issuer_name_source":null,"issuer_url":"/issuer/0001609809","owner_cik":"0001614936","owner_name":"Pomerantz Roger","owner_display_name":"Pomerantz Roger","owner_url":"/insider/0001614936","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30027.0,"shares_display":"30,027","price_per_share":25.734903919805507,"price_display":"25.73","price_state":"stated","total_value":772741.96,"total_display":"772,741.96","total_whole":"772,742","shares_owned_after":22727.0,"shares_owned_after_display":"22,727","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-05-05","filed_date":"2016-05-06","scope":"insider","n_lines":2},{"id":2495191,"accession":"0000899243-16-019420","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-16-019420","line_url":"/filing/0000899243-16-019420","is_derivative":false,"issuer_cik":"0001609809","issuer_name":"Seres Therapeutics, Inc.","issuer_ticker":"MCRB","issuer_name_source":null,"issuer_url":"/issuer/0001609809","owner_cik":"0001614936","owner_name":"Pomerantz Roger","owner_display_name":"Pomerantz Roger","owner_url":"/insider/0001614936","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":29298.0,"shares_display":"29,298","price_per_share":26.538875008533005,"price_display":"26.54","price_state":"stated","total_value":777535.96,"total_display":"777,535.96","total_whole":"777,536","shares_owned_after":22727.0,"shares_owned_after_display":"22,727","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-05-04","filed_date":"2016-05-06","scope":"insider","n_lines":2},{"id":3107256,"accession":"0000899243-16-019213","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0000899243-16-019213","line_url":"/filing/0000899243-16-019213","is_derivative":false,"issuer_cik":"0001609809","issuer_name":"Seres Therapeutics, Inc.","issuer_ticker":"MCRB","issuer_name_source":null,"issuer_url":"/issuer/0001609809","owner_cik":"0001614936","owner_name":"Pomerantz Roger","owner_display_name":"Pomerantz Roger","owner_url":"/insider/0001614936","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":23680.0,"shares_display":"23,680","price_per_share":28.005864864864865,"price_display":"28.01","price_state":"stated","total_value":663178.88,"total_display":"663,178.88","total_whole":"663,179","shares_owned_after":30069.0,"shares_owned_after_display":"30,069","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-05-03","filed_date":"2016-05-04","scope":"insider","n_lines":3},{"id":3107240,"accession":"0000899243-16-019213","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-16-019213","line_url":"/filing/0000899243-16-019213","is_derivative":false,"issuer_cik":"0001609809","issuer_name":"Seres Therapeutics, Inc.","issuer_ticker":"MCRB","issuer_name_source":null,"issuer_url":"/issuer/0001609809","owner_cik":"0001614936","owner_name":"Pomerantz Roger","owner_display_name":"Pomerantz Roger","owner_url":"/insider/0001614936","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":43687.0,"shares_display":"43,687","price_per_share":29.07084510266212,"price_display":"29.07","price_state":"stated","total_value":1270018.01,"total_display":"1,270,018.01","total_whole":"1,270,018","shares_owned_after":30976.0,"shares_owned_after_display":"30,976","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-05-02","filed_date":"2016-05-04","scope":"insider","n_lines":2},{"id":2766220,"accession":"0000899243-16-017930","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-16-017930","line_url":"/filing/0000899243-16-017930#line-3","is_derivative":false,"issuer_cik":"0001609809","issuer_name":"Seres Therapeutics, Inc.","issuer_ticker":"MCRB","issuer_name_source":null,"issuer_url":"/issuer/0001609809","owner_cik":"0001614936","owner_name":"Pomerantz Roger","owner_display_name":"Pomerantz Roger","owner_url":"/insider/0001614936","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9212.0,"shares_display":"9,212","price_per_share":30.0,"price_display":"30.00","price_state":"stated","total_value":276360.0,"total_display":"276,360.00","total_whole":"276,360","shares_owned_after":22727.0,"shares_owned_after_display":"22,727","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-04-07","filed_date":"2016-04-11","scope":"insider"},{"id":2160632,"accession":"0000899243-16-017713","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0000899243-16-017713","line_url":"/filing/0000899243-16-017713","is_derivative":false,"issuer_cik":"0001609809","issuer_name":"Seres Therapeutics, Inc.","issuer_ticker":"MCRB","issuer_name_source":null,"issuer_url":"/issuer/0001609809","owner_cik":"0001614936","owner_name":"Pomerantz Roger","owner_display_name":"Pomerantz Roger","owner_url":"/insider/0001614936","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":44825.0,"shares_display":"44,825","price_per_share":28.92342732849972,"price_display":"28.92","price_state":"stated","total_value":1296492.63,"total_display":"1,296,492.63","total_whole":"1,296,493","shares_owned_after":29931.0,"shares_owned_after_display":"29,931","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-04-04","filed_date":"2016-04-05","scope":"insider","n_lines":4},{"id":2160614,"accession":"0000899243-16-017713","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-16-017713","line_url":"/filing/0000899243-16-017713#line-4","is_derivative":false,"issuer_cik":"0001609809","issuer_name":"Seres Therapeutics, Inc.","issuer_ticker":"MCRB","issuer_name_source":null,"issuer_url":"/issuer/0001609809","owner_cik":"0001614936","owner_name":"Pomerantz Roger","owner_display_name":"Pomerantz Roger","owner_url":"/insider/0001614936","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":40506.0,"shares_display":"40,506","price_per_share":25.69,"price_display":"25.69","price_state":"stated","total_value":1040599.14,"total_display":"1,040,599.14","total_whole":"1,040,599","shares_owned_after":73184.0,"shares_owned_after_display":"73,184","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-04-01","filed_date":"2016-04-05","scope":"insider"},{"id":2160611,"accession":"0000899243-16-017713","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-16-017713","line_url":"/filing/0000899243-16-017713#line-3","is_derivative":false,"issuer_cik":"0001609809","issuer_name":"Seres Therapeutics, Inc.","issuer_ticker":"MCRB","issuer_name_source":null,"issuer_url":"/issuer/0001609809","owner_cik":"0001614936","owner_name":"Pomerantz Roger","owner_display_name":"Pomerantz Roger","owner_url":"/insider/0001614936","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":38080.0,"shares_display":"38,080","price_per_share":26.67,"price_display":"26.67","price_state":"stated","total_value":1015593.6,"total_display":"1,015,593.60","total_whole":"1,015,594","shares_owned_after":35104.0,"shares_owned_after_display":"35,104","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-04-01","filed_date":"2016-04-05","scope":"insider"}],"collapsed":true,"next_cursor":"2016-04-01|2160611","ledger_fault":false,"count":{"value":51,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":2,"open_market":true},{"code":"S","label":"Open-market sale","n":49,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":51},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001609809","name":"Seres Therapeutics, Inc.","url":"/issuer/0001609809","role":"Director, Officer (President and CEO)","n_filings":19,"first_seen":"2016-04-05","last_seen":"2018-09-11"},{"type":"issuer","type_label":"ISSUER","cik":"0001709401","name":"Rubius Therapeutics, Inc.","url":"/issuer/0001709401","role":"Director","n_filings":1,"first_seen":"2018-07-23","last_seen":"2018-07-23"},{"type":"issuer","type_label":"ISSUER","cik":"0001478069","name":"CONTRAFECT Corp","url":"/issuer/0001478069","role":"Director","n_filings":1,"first_seen":"2017-07-26","last_seen":"2017-07-26"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001614936","retrieved_at":"2026-08-24T11:02:44+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}